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ing capacity of virus) of potentially immunogenic pep-
tides, TCD8 responses are predominantly directed to
a few peptides (sometimes a single peptide), termed
“immunodominant” determinants. Other “subdominant”
determinants elicit fewer responding TCD8. Narrow re-
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Centro Nacional de Microbiologı´a sponses favor the emergence of viral escape mutants.
For unknown reasons TCD8 responses to some immuno-Instituto de Salud Carlos III
E-28220 Madrid dominant determinants exert poor antiviral activity and
compromise the effectiveness of the TCD8 response.Spain
ID in antiviral responses results from a complex com-
bination of factors that encompass all aspects of TCD8
biology, including: (1) generation of the TCD8 repertoire,Summary
(2) interaction of TCD8 with professional antigen-pre-
senting cells (pAPC) in lymphoid organs, (3) generationHighlights from a Fundacio´n Juan March Interdisci-
plinary Meeting. CD8 T cells (TCD8) play a critical role of class I peptide complexes from viral antigens synthe-
sized by pAPCs (“direct priming”) or acquired by pAPCsin immunity to viruses. A central feature of antiviral
TCD8 responses is immunodominance: out of thou- from virus-infected cells (“crosspriming”), and (4) com-
petition between TCD8 clones for activation. The com-sands of potential target peptides, only a handful gen-
erate measurable responses. A recent Fundacio´n Juan plex problem of ID is poised for a quantum leap in under-
standing due to the introduction of new technologies,March Meeting brought together scientists working
on the various steps in antigen presentation and T cell many of which were on display at a meeting entitled:
“Immunodominance: The Key to Understanding and Ma-biology that contribute to immunodominance, whose
understanding is key to rationally developing vaccines nipulating CD8 T Cell Responses to Viruses,” spon-
sored by the Fundacio´n Juan March in Madrid, Spainmeant to elicit effective antiviral TCD8 responses.
on June 7–9, 2004.
Introduction
Viruses pose a serious threat to living organisms. In ID in Mouse, Monkey, and Human
response, jawed vertebrates evolved a multilayer im- Much of what we know about ID has been gleaned from
mune response that includes one of evolution’s great infecting B6 or BALB/c mice with model viruses, particu-
creations, the MHC class I-CD8 T cell (TCD8) immuno- larly influenza A virus (IAV). Responses to approximately
surveillance system. Nearly all cell types constitutively ten well-defined IAV determinants in each inbred strain
express class I molecules, which bind oligopeptides form a hierarchy that evolves during the transition form
generated through the action of proteasomes and other the primary to the memory phase of the response and
proteases. By displaying oligopeptides on the cell sur- that is highly reproducible between individuals of a given
face, class I molecules enable TCD8 to monitor cells for strain. But how diverse is the total antiviral response?
viral infection. Since a prime source of viral peptides are Jonathan Yewdell (NIAID, Bethesda, Maryland) showed
defective ribosomal products (DRiPs), rapidly degraded HPLC fractionation of peptides eluted from IAV-infected
forms of newly synthesized proteins, TCD8 can detect cells that suggests that mice mount low-frequency re-
viruses shortly after they initiate infection and exert their sponses to a large number of undefined peptides. These
antiviral effects before progeny viruses are released. may be completely distinct determinants from the de-
The past decade has witnessed an explosion in our fined sets or they may represent extended, shortened,
capacity to probe and understand antiviral TCD8 re- or posttranslationally modified versions of defined de-
sponses. It is now possible to define viral peptide deter- terminants. Margarita Del Val (Instituto de Salud Carlos
minants recognized by TCD8, accurately quantitate TCD8 III, Madrid, Spain) showed that in addition to the “opti-
responding to defined determinants, and measure func- mally” sized peptide used to gauge TCD8 responses to
tional capacities of TCD8 on a determinant-by-determi- an HIV protein, cells present two extended versions as
nant basis. While TCD8 cannot generally provide steriliz- well as a shortened version. The truth is that precious
ing immunity to viruses, they make a major contribution little is known about the viral “immunopeptidome”; i.e.,
to controlling viral infections. In the case of human im- the diversity and abundance of viral peptides presented
munodeficiency viruses (HIV), TCD8 may be the best to the immune system.
hope for developing a preventive vaccine. Therapeutic Inbred mice express two or three different class I
TCD8 vaccines may be of benefit for other infectious allomorphs, while humans can express up to six distinct
diseases and tumors, as well. allomorphs. How does the increased complexity of the
A major hurdle to developing vaccines that generate displayed viral immunopeptidomes affect the ID hierar-
effective TCD8 responses is immunodominance (ID) chy? There are no data for direct comparison between
(Yewdell and Bennink, 1999). Despite the presence of mouse and human responses to similar pathogens act-
thousands to tens of thousands (depending on the cod- ing under similar conditions (e.g., initial encounter). Most
data in humans have been obtained with human immu-
nodeficiency virus (HIV), which like many clinically signif-*Correspondence: jyewdell@nih.gov
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icant viruses, does not infect mice. Richard Koup (NIAID, terminants. In contrast to CMV, TCD8 prefer gene prod-
ucts predicted to be expressed late in the vaccinia infec-Bethesda, Maryland) summarized current knowledge.
On average, chronically infected patients on anti-HIV tious cycle. This underscores the reality that virus
systems exhibit unique features based on the precisechemotherapy respond to approximately four determi-
nants. In some individuals, TCD8 to single determinants nature of the virus-host interaction. Variola virus (the
cause of smallpox) is highly specific for humans andaccount for90% of responses. Response magnitude is
not strictly related to clinical status. HLA-B57-restricted cannot be studied in mice. Luis Sigal (Fox Chase Cancer
Center, Philadelphia, Pennsylvania) described the ectro-TCD8 are strongly associated with decreased pathogen-
esis. Understanding this observation could provide criti- melia model in mice, which is similar in many respects
to human smallpox.cal insight into effective vaccine strategies for HIV. The
road to an effective HIV vaccine probably passes Jose´ A. Lo´pez de Castro (Centro de Biologı´a Molecu-
lar, Madrid, Spain) described the careful comparisonthrough the SIV-macaque system. David Watkins (Uni-
versity Wisconsin) reported that though responses to of over 1000 natural ligands of HLA-B27 expressed in
mouse or human cells. The peptide repertoire of thisindividual determinants frequently predominate during
chronic infection, animals may respond to up to 70 de- human class I allomorph diverged 15%–25% between
the two species. More than half of the divergence couldterminants during acute infection. TCD8 responding to
different determinants exhibit gross differences in their not be ascribed to species-specific differences in pro-
tein sequences but was rather accounted for by differen-capacity to reduce viral replication in vitro. Koup and
Watkins concurred that effective TCD8-based HIV vac- tial tapasin and proteasome-mediated effects.
Ann Hill (Oregon Health Science University, Portland,cines may require the induction of TCD8 responses to
peptides that first, are from regions of structurally con- Oregon) used a genomic library to identify 18 mouse
CMV (mCMV) determinants recognized during the acutestrained parts of proteins (to prevent selection of escape
mutants), and second, for reasons that need explana- phase of the infection in B6 mice. Importantly, the estab-
lishment of latent infection with no detectable infectioustion, represent effective targets.
Herpesviruses and poxviruses provide a great chal- virus is accompanied by alterations in the ID hierarchy.
As described in acute virus systems previously, therelenge for immunodominologists, since their genomes
encode more than ten-fold the number of potential de- is no simple relationship between the ID rank of a deter-
minant and the functional avidity of responding TCD8.terminants as IAV or HIV. Louis Picker (Oregon Health
Science University, Portland, Oregon) discussed human The dominance hierarchy was clearly affected by genes
outside of the MHC and NK-resistance loci. This is anT cell responses to cytomegalovirus (CMV), a herpesvi-
rus that chronically infects most humans. Picker used important finding since virtually nothing is known about
the influence of background genes on ID, which maya panel of 13,684 (!) synthetic peptides corresponding
to a complete set of overlapping (by 10 residues) 15- explain some of the variability in human responses noted
above. mCMV is known to express at least threemers from all 213 in silico-predicted CMV open reading
frames (ORFs) to measure TCD8 (and TCD4) responses “VIPRs.” Surprisingly, although deleting these genes in-
creases in vitro presentation of all five defined determi-in 33 chronically infected and 9 uninfected individuals.
On average, 10% of TCD4 or TCD8 in peripheral blood nants tested, VIPR-less mCMV establishes a chronic
infection, and induces an indistinguishable responsewere CMV specific, despite the fact that CMV expresses
multiple “VIPRs”: viral gene products that interfere with from wild-type virus in both acute and chronic phases.
Matthias Reddehase (University of Mainz, Mainz, Ger-antigen presentation. Individuals detectably responded
to determinants encoded by an average of 12 (TCD4) many) analyzed the ID hierarchy of seven determinants
defined in mCMV-infected BALB/c mice and found thatand 7 (TCD8) ORFs. Although representing just 4% of
the CMV genome, CMV proteins synthesized initially in contrary to B6 mice, this does not change upon estab-
lishment of latency. The ID hierarchy in BALB/c micethe infectious cycle elicited 28% of the responding TCD8.
Non-CMV infected individuals demonstrated only seven also remains unaffected by deleting the three VIPRs.
Importantly, TCD8 specific for any of the seven definedTCD8 responses and no TCD4 responses to the entire
peptide panel. This led Picker to propose that memory determinants were able to protect against lethal mCMV
infections. This raises hope for the efficacy of vaccinesT cell crossreactivity between CMV and commonly en-
countered non-CMV agents is unusual, and thus, such that induce TCD8 responses to subdominant determi-
nants that have otherwise preferred properties such ascrossreactivity may not have the dominant influence on
the memory repertoire of humans as has been demon- conservation due to structural constraints to their varia-
tion. By contrast, TCD8 cells specific for the immuno-strated in mouse systems.
Alex Sette (La Jolla Institute of Immunology, San dominant determinant in B6 mice were completely non-
protective. This is explained by the negative effect ofDiego, California) described a similarly ambitious project
to define human TCD8 responses to vaccinia virus, infor- VIPRs on presentation in productively infected cells,
since the same TCD8 protect against VIPR-less mCMV.mation that will be important for benchmarking re-
sponses induced by safer alternatives to standard small- Thus, TCD8 may be activated by crosspriming rather
than by direct priming (discussed in detail below). Thispox vaccination. Using a panel of 7,000 peptides
encompassing all determinants predicted in silico to neatly makes the point that the effects of VIPRs can be
highly specific for individual determinants, and that IDbind to class I allomorphs from each of the nine human
“supertypes,” Sette examined TCD8 responses in trans- as defined by the magnitude of a determinant-specific
response does not always match “ID as defined by thegenic mice expressing HLA-A2, A11, or B7. In each
transgenic strain, 25 peptides were recognized, with generation of protective immunity.
Peter Doherty (University of Melbourne, Melbourne,25%–75% of the response focused on one to three de-
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Australia) and Weisan Chen (Ludwig Institute, Mel- to expression of the proper costimulatory molecules or
ability to interact with TCD8 in lymphoid organs since allbourne, Australia) described the swapping between
TCD8 responding to dominant (PA224-232) and subdomi- of the DC subsets are capable of priming if the DCs are
exposed to synthetic peptide antigens. Thus, CD8nant (NP366-374) determinants in primary and memory re-
sponse to IAV. The phenomenon is complex and can CD205 DC seems to have a special ability to acquire
or process protein antigens. This does not necessarilybe reversed by a number of manipulations that reduce
activation of the now dominant memory NP366-374-specific occur at the site of viral infections, but may occur in the
lymph node by antigen transfer from tissue DC.TCD8 or by increasing presentation of the PA224-232 in
secondary immunization. A critical question posed by Jacques Nefjees (Netherlands Cancer Institute, Am-
sterdam, Netherlands) showed that DC can obtain pep-the studies is the extent to which memory TCD8 can
be activated by non-pAPCs, pointing to the dearth of tides through gap junctions they form with surrounding
cells. In principle, this remarkable mechanism enablesinformation regarding the requirements for costimulation
of memory TCD8 and how this might differ between TCD8 DCs to monitor the peptides generated by surrounding
cells in tissues and lymphoid organs.located in lymphoid versus peripheral organs.
Jose´ Villadangos (The Walter and Eliza Hall Institute,
Melbourne, Australia) reported that CD8 CD205 DCRoutes of Antigen Presentation In Vivo
can only crosspresent antigen captured by actin-depen-The contribution of crosspriming versus direct priming
dent mechanisms (i.e., phagocytosis or macropino-to induction of antiviral TCD8 responses is a contentious
cytosis). Intriguingly, maturation of DC by LPS or CpG-topic. Jonathan Yewdell showed that crosspriming with
rich oligonucleotides inhibited macropinocytosis andIAV-infected cells results in a robust response exhibiting
crosspriming in CD8 CD205 DC in vitro. LPS or CpGsimilar ID hierarchy as immunization with IAV itself. This
treatment of mice resulted in the complete loss of TCD8implies that IAV-responses are either normally induced
responses against subsequent antigenic challenge 9 hrby crosspriming or that crosspriming and direct priming
later by crosspriming or viruses. Importantly, these find-induce a highly similar response. The latter would be
ings imply that antigen presentation can only occurpredicted if crosspriming is based on the transfer of
within a limited time frame in a local inflammation dueprocessed peptides from donor cells to pAPCs. Yewdell
to maturation of immature DC. Maria Montoya (Edwarddiscussed recent findings that instead suggest that
Jenner Institute, Compton, United Kingdom) discussedcrosspriming is based on transfer of proteasome sub-
how splenic CD11 DCs enter apoptosis within 2 daysstrates and not proteasome products. Sebastian Joyce
of infection of mice with lymphocytic choriomeningitis(Vanderbilt University, Nashville, Tennessee) empha-
virus.sized that whatever the physical nature of transferred
Vincenzo Cerundolo (University of Oxford, Oxford, UK)material, it represents a finite source of antigen. There-
showed that in vivo activation of NKT cells via oral orfore, the half-life of cell surface peptide-MHC complexes
parenteral administration of -galactosylceramide in-displayed should play a more important role in cross-
duced DC maturation and enhanced primary and mem-priming than in direct priming, where biosynthesis con-
ory TCD8 responses to soluble protein and peptide anti-stantly supplies peptides.
gens. NKT cell activation represents, therefore, anotherKenneth Rock (University of Massachusetts Medical
target for TCD8 vaccine adjuvants.School, Worcester, Massachusetts) presented data dem-
onstrating that crosspriming occurs via TAP-dependent
and -independent pathways, with the former accounting Antigen Processing Filters Influencing ID
The most important factor in shaping the immunopepti-for perhaps 80% of responses. Intriguingly, TAP-inde-
pendent crosspriming is impaired in cathepsin S dome is the individual’s set of class I allomorphs. But
class I molecules can only present peptides that are(CatS)/ mice but not CatL/ or CatB/ mice. CatS
appears to be involved in endosomal peptide genera- provided to them by the antigen processing machinery.
Jacques Neefjes presented evidence that contrary totion. Most importantly, IAV-infected CatS/ mice dem-
onstrate reduced responses to two defined IAV determi- prevailing models of antigen processing, cellular protea-
somes most frequently generate peptides greater thannants, suggesting that TAP-independent crosspriming
participates in generating anti-IAV TCD8 responses. It 17 residues that must be trimmed by tripeptidyl pepti-
dase II (TPPII).will be important in future studies to determine the over-
lap between peptidomes generated by secretory/endo- Peter Van Endert (Necker Institute, Paris, France) de-
scribed the contribution of TAP to shaping the humansomal versus cytosolic/ER proteases and class I loading
mechanisms: surely the sets cannot overlap completely, immunopeptidome based on selectivity for the three
NH2-terminal residues and the COOH terminus of trans-and TCD8 may be generated against endosomally pro-
cessed peptides that are unable to recognize virus-in- ported peptides. COOH-terminal filtering has a great
impact on the immunopeptidome since ER is essentiallyfected cells (and vice versa).
A critical issue in crosspriming and direct priming is devoid of carboxypeptidase activities. NH2-terminal fil-
tering has a less direct effect, since peptides arethe identities of the pAPC that are active in the process.
William Heath (Walter and Eliza Hall Institute, Melbourne, trimmed by ER aminopeptidases. Van Endert described
two ER peptidases with distinct specificities that partici-Australia) described the six defined mouse DC subsets.
Despite constituting 10% of all DCs, CD8 CD205 pate in antigen processing, human ERAP1 and ERAP2.
Although each is functional when studied separatelyDC appear to be responsible for nearly all priming (po-
tentially crosspriming) to viruses and crosspriming to in vitro, ERAP1 forms a heterodimer with ERAP2 that
may be required for efficient trimming of longer andsoluble proteins and parasites. This is not simply due
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more complex NH2-terminal extensions. There are many of class I molecules (and other cell surface proteins)
observed by Marrack and others. Patients with geneticpuzzling features that remain to be explored, including
highly disparate expression of the two enzymes in differ- defects in perforin secretion demonstrate impaired re-
sponse to infections, and a surprising failure to contractent tissues, possible association with the class I loading
complex, and the absence of an ERAP2 homolog in the numbers of activated TCD8 after the primary infec-
tion. Intriguingly, this also occurs in certain patients withmice.
fully normal secretion of perforin-containing granules.
Griffiths suggested that this may be due to a defect inFocusing on TCD8
the ability of TCD8 to acquire target membranes fromOne of the least understood factors in ID is the T cell
APCs, and that TCD8, like those from perforin deficientrepertoire. TCD8 precursor frequency plays an important
patients, may not be susceptible to fratricidal lysis,role in establishing the ID hierarchy in minor histocom-
which may contribute to the contraction phase.patibility systems (Sebastian Joyce). Todd Schell (Penn-
Ulrich von Andrian (Harvard Medical School, Boston,sylvania State University College of Medicine, Hershey,
Massachusetts) showed remarkable movies chroniclingPennsylvania) showed that tolerance can greatly shape
the interaction of naive T cells with DCs in live micethe ID hierarchy to foreign antigens by deleting TCD8
as visualized by multiphoton microscopy. Mature DCsspecific for immunodominant determinants and sparing
newly arriving into lymph nodes cluster around venules,only the lowest affinity TCD8 specific for the least immu-
exhibiting random movement. TCD8 immigrants exhibitnogenic determinants.
high motility, then slow after a few hours and establishPeter Doherty reported that systematic sequencing
prolonged contacts with mature DCs that are length-of TCR genes from single cell sorts of TCD8 specific for
ened further if DCs present the appropriate antigen. Adominant and subdominant IAV determinants reveals
day after transfer, TCD8-DC interactions become brieferconsiderable differences in diversity and CDR3 length
and TCD8 begin dividing in earnest. Circulating bloodin TCRs responding to the two determinants. More such
DC enter the bone marrow where they can present anti-studies will be needed to arrive at useful generalizations
gens to the central memory TCD8 which reside there.relating these factors to ID.
TCD8-DC interaction dynamics were dissimilar fromBenedita Rocha (Necker Institute, Paris, France) used
those observed in the peripheral node, possibly duesingle cell PCR to measure levels of mRNA encoding
to differences between microenvironments or between20 distinct genes in studying the dynamics of naive and
memory versus naive TCD8.memory T cell activation. Surprisingly, expression of
genes encoding cytokines, their receptors, and lytic ma-
chinery occurs at random and in widely varying amounts The Future of ID
A clear message from the meeting is that ID, like mostin individual cells during the early (day 4) primary re-
sponse. Three days later, concerted expression of these immunological phenomena, is the complex net result of
interactions between a number of processes, them-genes is finally achieved in activated TCD8. Disappear-
ance of gene activity in the contraction phase is again selves highly complex. A reasonable understanding of ID
will only come from the combined efforts of biochemists,random at the single cell level. Memory TCD8 respond
to antigen within hours with a concerted and efficient cell biologists, cellular immunologists and biomathema-
ticians. Interdisciplinary meetings such as this are es-expression of effector gene products. Characterization
of TCD8 by RNA and protein profiling may provide the sential to create and maintain lines of communication
between these groups.key to understanding determinant specific differences
in anti-viral activity that plague development of TCD8- Increasingly, we will have to turn to mathematical
modelers for a reality check. Readers might chuckle atbased vaccines for HIV and other “difficult” pathogens.
Philippa Marrack (HHMI, Denver, Colorado) studied “reality check,” for they probably share the opinion of
most biologists that assumptions used to create mathe-the mechanism of immunodomination, which is a major
contributor to ID in many viral systems. TCD8 recognizing matical models frequently gloss over reality. This will
be less true in the future as our knowledge grows inantigen on a pAPC inhibit proliferation of other TCD8
engaged with the same pAPC. As only dividing cells sophistication and our abilities improve to accurately
quantitate nature in all of its fine and glorious details.mature into memory TCD8, this ought to have a large
effect on the numbers of memory cells. Paradoxically, Fittingly, the meeting concluded with Rob De Boer
(University of Utrecht, Utrecht, Netherlands) presentingdiscrepancies in ID hierarchies seem to narrow in sec-
ondary responses. The mechanism for immunodomina- a mathematical model for T cell responses to an acute
viral infection in mice. He showed that a few simple firsttion is uncertain. TCD8 can clearly be observed to non-
specifically deplete peptide class I complexes from order equations could explain the differential expansion,
contraction and memory phases that define the life ofAPCs in vitro but the in vivo relevance of this phenome-
non is uncertain. Marrack suggested that dominating T cells. A surprising and novel conclusion from this
model is that slight differences (15%) in division ratesTCD8may physically sequester APCs, or monopolize co-
stimulatory signals or cytokines provided by pAPCs. of individual clonotypes or in initial time of activation
have a large impact (10-fold) on the magnitude of theResolving these possibilities will probably require vis-
ualizing the TCD8-APC interaction. Gillian Griffiths (Uni- response at the peak of activation. As these differences
are bound to exist in biological processes, De Boer con-versity of Oxford, Oxford, UK) used confocal microscopy
to study the interaction of TCD8 with target cells. Mem- cluded that ID is nearly an inevitable outcome of nature.
In practical terms, it is clear that ID will provide abrane fusion between the two cells frequently can be
found in such synapse, which results in the transfer hurdle to vaccine development. Immunodomination by
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TCD8-specific for determinants from vector proteins limit
responses to inserted genes (shown in humans by Cer-
undolo for a vaccinia virus vaccine). Funding agencies
should devote significant resources to develop im-
proved vectors that provide a minimum of extraneous
antigens to the immune system. Immunodomination
may also dictate that vaccines meant to elicit responses
to multiple targets be given as single antigen vaccines
in multiple sites that access anatomically distinct lymph
nodes – which is contrary to the current trend in vaccine
administration. Obviously, rational vaccine design de-
pends on understanding the relative contribution of
crosspriming and direct priming, the cell biological
mechanisms underlying these processes, and the identi-
ties and properties of pAPCs.
Above all, we need to understand allomorph/determi-
nant-based differences in immune effector functions.
Just as humoral vaccines aim at inducing antibodies that
effectively neutralize viral infectivity, cellular vaccines
should aim at inducing TCD8 that exert effective antiviral
activity. This means deepening our understanding of:
(1) TCD8 antiviral effector functions, (2) how positive and
negative selection processes influence the TCD8 reper-
toire against dominant versus subdominant antigens,
(3) nuances in TCD8 activation that lead to differential
acquisition and application of effector activities in the
afferent and efferent stages of activation, (4) differential
processing and presentation of target antigens by virus-
infected cells, including the cell type-dependent effects
of VIPRs, and (5) how to minimize or counter selection
of virus mutants that escape TCD8 action.
Sadly, Fundacio´n Juan March has decided to termi-
nate this series of meetings. In addition to generous
funding, the Fundacio´n provided a professional staff
that cheerfully and efficiently attended to every task: the
scientific organizers’ sole job entailed speaker selection.
The Juan March meetings have profoundly impacted
Spanish science. Due to their intimate size and the high
quality of participants (who can resist the charms of
Madrid?), they facilitated international scientific prog-
ress in a manner disproportionate to their cost. Perhaps
a plea from the scientific community might persuade
the Fundacio´n to reconsider its decision: http://www.
march.es/contactar/contactar.asp.
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